Pharming Group N.V. (PHAR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.26B |
| Enterprise Value | 1.23B |
| P/E Ratio | 73.14 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 2.08 |
| Price/Book Ratio | 2.96 |
| Enterprise/Revenue | 1.99 |
| Enterprise/EBITDA | 20.46 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.03 |
| Operating Margin | 0.04 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 376.13M |
| Revenue/Share | 5.17 |
| Gross Profit | 330.63M |
| EBITDA | 34.78M |
| Net Income | 2.85M |
| Diluted EPS | 0.04 |
Balance Sheet
| Total Cash | 158.28M |
| Total Cash/Share | 2.24 |
| Total Debt | 113.3M |
| Total Debt/Equity | 0.49 |
| Current Ratio | 3.01 |
| Book Value Per Share | 3.63 |
Price History
| 52-Week Change | -26.96 |
| 52-Week High | 21.34 |
| 52-Week Low | 9.62 |
| Moving Average 50 Days | 12.18 |
| Moving Average 200 Days | 15 |
Statistics
| Average Volume | 13,869 |
| Shares Outstanding | 70.78M |
| % Held by Institutions | 3.2 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
